Collection, Evaluation and Assessment of Adverse Drug Reactions on the Oncology Ward
Status
Conditions
Treatments
Details and patient eligibility
About
The proposed cohort study collected within a 5-month observation period adverse drug reaction (Adverse Drug Events - ADE) in patients at the Department of Oncology at the University of Zurich. ADE have been recorded using prospective monitoring and assessed using standardized algorithms regarding causality and severity. Data sources included information from the medical records, laboratory values and internal rounds. Additional information has been collected using a standardized patient questionnaire.
The primary endpoints of this study are to determine the frequency of ADE, the comparison of the quality of data sources and collection methods for the detection of ADE in regard to patient characteristics, size, number of medications, the category of ADE, severity, causation, diagnosis, hospitalization, cause of hospitalization and medication cause. Secondary endpoint is the assessment of the ADE causality, severity and predictability.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
- German-speaking patients,
- At least 18 years old.
Exclusion criteria
- Patients who could not give her consent, or have given, and any minor patient.
Trial design
129 participants in 1 patient group
Trial contacts and locations
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal